American Medical Association, JAMA Oncology, 2(9), p. 168, 2023
DOI: 10.1001/jamaoncol.2022.5826
Full text: Unavailable
This Viewpoint discusses immunohistochemistry and tissue-hybridization-based diagnostics delivery and compares it with digital pathology.